Superworth

Arcturus Therapeutics profit margin ARCT

Gross, operating and net profit as a share of revenue over the last twelve months, from 2019.

Net margin, 12 months
n/m
not a meaningful number
Peer median
11.2%

Arcturus Therapeutics' net margin works out at −318% over the last twelve months, but it is not a meaningful number: a margin outside minus 100% to 100% is moved by items that are not sales.

Profit margin over time

OperatingNet

Open the interactive chart, with overlays and comparisons

Fiscal year by fiscal year

Fiscal yearNet marginOperating margin
FY2025−80.2%−93.0%
FY2024−53.1%−62.8%
FY2023−17.8%−46.9%
FY20224.5%5.9%
FY2021n/an/a
FY2020n/an/a
FY2019n/an/a
FY2018n/an/a

Quarter by quarter

QuarterEndedNet margin, 12 monthsChange on a yearOperating margin
Q2 FY26n/an/an/a
Q1 FY26n/an/an/a
Q4 FY25−80.2%−27.1 pts−93.0%
Q3 FY25−68.3%−29.3 pts−80.3%
Q2 FY25−49.3%−5.4 pts−59.4%
Q1 FY25−47.5%+38.7 pts−57.1%
Q4 FY24−53.1%−35.3 pts−62.8%
Q3 FY24−39.1%−72.6 pts−50.2%
Q2 FY24−43.9%−74.3 pts−54.4%
Q1 FY24−86.2%−125.8 pts−99.1%
Q4 FY23−17.8%−22.4 pts−46.9%
Q3 FY2333.5%n/a20.8%

Against its peers

Companies in Drug Manufacturers - General nearest Arcturus Therapeutics' size, closest first, today.

CompanyProfit margin
ARCTArcturus Therapeuticsn/m
NATRNatures Sunshine Products3.7%
ARVNArvinas2.9%
PBYIPuma Biotechnology11.6%
IRWDIronwood Pharmaceuticals33.4%
ZVRAZevra Therapeutics42.8%
CRMDCorMedix40.5%
COLLCollegium Pharmaceutical5.9%
ABUSArbutus Biopharma84.2%
LFVNLifevantage2.8%
AMPHAmphastar Pharmaceuticals10.8%
Peer median11.2%

What the profit margin tells you

Profit as a share of revenue at three levels: gross (after making the product), operating (after running the business) and net (after everything, including tax and interest).

Compare within an industry. 10% is superb for a retailer and poor for a software company.

More on Arcturus Therapeutics

Valuation data, not investment advice. Prices as of . Reported figures come from the company's filings with the SEC.